Peer-reviewed findings on plaque reduction and oxidative stress are renewing debate over diet-based approaches to cardiovascular disease.
By yourNEWS Media Newsroom
Heart disease remains the leading cause of death worldwide, and most conventional treatment strategies focus on long-term drug management rather than reversing underlying arterial damage. However, a body of clinical research has drawn renewed attention to pomegranate juice after investigators documented measurable improvements in markers associated with atherosclerosis.
In a study published in Clinical Nutrition, patients with advanced carotid artery stenosis who consumed pomegranate juice daily experienced a significant reduction in carotid intima-media thickness, a standard indicator used to assess arterial plaque burden. Over the course of a year, researchers observed progressive decreases in arterial wall thickness among participants who consumed the juice, while plaque progression continued in those who did not.
The findings were accompanied by additional cardiovascular changes. Researchers reported reductions in systolic blood pressure, marked declines in oxidative stress affecting low-density lipoprotein (LDL) cholesterol, and increased activity of paraoxonase-1, an enzyme linked to high-density lipoprotein (HDL) that helps protect blood lipids from oxidation. Oxidized LDL is widely regarded as a contributor to inflammation and plaque development within arterial walls.
Scientists involved in the research attributed the effects to pomegranate’s unusually high concentration of polyphenols, including tannins and anthocyanins, compounds known for antioxidant and anti-inflammatory properties. Laboratory work has previously shown these compounds can interfere with lipid oxidation, a key mechanism in the progression of cardiovascular disease.
Independent health researchers and analysts, including those cited by GreenMedInfo.com, have pointed to the study as notable because dietary interventions are more commonly associated with slowing disease progression rather than reversing existing plaque. Still, cardiologists caution that the trial involved a relatively small patient group and that larger, long-term studies would be needed before dietary guidance could shift clinical standards.
The research has nonetheless fueled broader discussion about the role of whole foods in cardiovascular health. Nutrition experts emphasize that diets rich in fruits, vegetables and other polyphenol-dense foods are consistently linked to improved vascular outcomes, and pomegranate juice is increasingly evaluated within that broader dietary pattern rather than as a standalone therapy.
Critics of the current drug-centered model argue that promising nutrition research often receives limited attention compared with pharmaceutical approaches. Commentary from outlets such as NaturalNews.com has highlighted concerns that non-patentable interventions face structural barriers to widespread adoption, while supporters of conventional medicine stress the importance of evidence standards and patient safety.
Medical professionals continue to advise that pomegranate juice should not replace prescribed therapies, particularly for patients with advanced cardiovascular disease. However, many acknowledge that incorporating nutrient-dense foods into a balanced diet carries relatively low risk and may offer complementary benefits alongside standard care.
As interest grows in food-based strategies for long-term health, tools such as BrightAnswers.ai are increasingly being used by researchers and the public alike to explore peer-reviewed nutrition science. Whether future large-scale trials confirm plaque-reducing effects, the existing findings have already contributed to renewed examination of how dietary components interact with the biological processes underlying heart disease.
Source: Natural News
Original article
Comments